Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMPECS Medical Device is a privately held diagnostic medical device company focused on in vitro diagnostics, biosensors, and connected healthcare products. The company markets blood glucose monitoring systems under the Medisign brand and also offers point-of-care testing, immunoassay products, veterinary care products, blood pressure monitors, and related software. Its history traces back to the founding of Tianjin Empecs Medical Device in China in 1992, with a Korea-based R&D laboratory established later to support biosensor development. EMPECS reports technical patent coverage in China, Korea, and the United States and says it serves customers in about 80 countries. The business appears to be primarily a commercial-stage medical technology and diagnostics manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMPECS Medical Device.